OncoSec Medical Inc (ONCSQ)

[guti]

yes, and like I wrote earlier, it is being used by Oncosec though a license agreement, and they do not own a patent specifically for its use, since it has been around and studied for many years already. Notice that Oncosec has recently trademarked the name ImmunoPulse but it does not include IL-12. Oncosec's goal is to use the ImmunoPulse platform with many other drugs and other types of Interleukins like IL-15, which it has already secured the license again from the University of South Florida, who owns both Patents for the electroporation use of IL-12 and IL-15.